ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 599

Is There Any Gender Specific Difference in the Cut Off Values of Ankylosing Spondylitis Disease Activity Score (ASDAS) in Patients with Axial Spondyloarthritis?

Erkan Kilic1, Gamze Kilic1 and Salih Ozgocmen2, 1Division of Rheumatology, Dept. PRM, Erciyes University, Faculty of Medicine, Kayseri, Turkey, 2Division of Rheumatology, Dept.PRM, Erciyes University, Faculty of Medicine, Kayseri, Turkey

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disease Activity, Validity and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

Background/Purpose

Axial spondyloarthritis (ax-SpA) consisted patients with advanced axial SpA or ankylosing spondylitis (AS) and non-radiographic axial SpA (nr-axSpA). Evaluation of disease activity in axSpA is complex due to the phenotypic heterogeneity of the disease. Assessment in Spondyloarthritis international Society (ASAS) endorsed the cut off values for ASDAS-CRP. The aim of this study was to assess the validity of AS Disease Activity Score (ASDAS)-CRP and ASDAS-ESR as clinical tools for assessing disease activity in axSpA and to estimate the cut-off values of ASDAS-CRP and ASDAS-ESR for male and female patients with axSpA.

Methods

Patients with axSpA were recruited from Erciyes Spondyloarthritis Cohort (ESPAC) and assessed for BASDAI, ASDAS, BASFI, BASMI, Ankylosing Spondylitis Quality of Life (ASQoL), and VAS-pain. Patients were grouped into low and high disease activity according to the physician’s (DrG) and patient’s global (PtG) assessment score (>6/10 vs <4/10), ASAS partial remission criteria, treatments and presence of peripheral arthritis. The discriminant ability of ASDAS-CRP and ASDAS-ESR was assessed using standardized mean differences. Receiver operating characteristic (ROC) curves were used for comparisons. Optimal cut-off values of ASDAS-CRP and ESR were calculated for both genders and for the whole group.

Results

Three hundred fifty-eight patients with axSpA (138 F, 220 M) were included in this study. One hundred sixty two patients met criteria for non-radiographic axSpA (nr-axSpA) and 196 for ankylosing spondylitis. Two ASDAS versions and BASDAI had good correlations with PtG and DrG in both groups, however correlation coefficients were relatively higher in men. Women had significantly higher VAS-pain, BASDAI item scores, PG and DrG and ESR. Discriminant ability of ASDAS-CRP, ASDAS-ESR and BASDAI were similar in men and women when patients were assigned into low and high disease activity based on the ASAS partial remission, PtG and DrG scores (assessed by comparing AUC of ROC curves). ASDAS cut-off values are quite similar in all groups indicating that ASDAS-CRP works similarly well in male and female patients with axSpA. The calculated ASDAS-CRP cut-offs in both genders were very similar to predefined values by ASAS except the cut off for in-active to moderate disease activity. The cut-off values for ASDAS-ESR seem to be lower than predefined values and women tent to have higher cut-offs compared to males.  

Conclusion

The construct validity of ASDAS-CRP to discriminate low and high disease activity and cut off values are similar in male and female patients with axSpA, however cut offs for ASDAS-ESR need to be redefined.

 

 

ASDAS-CRP

 

 

ASDAS-ESR

 

 

In-active-moderate

 

Moderate-High

High-Very high

In-active-moderate

Moderate-High

High-Very high

Whole group

1.57-1.69

1.93-2.34

3.40-3.92

1.43

1.82-2.06

3.25-3.57

Females

1.55-1.73

2.00-2.33

3.34-3.83

1.69-1.76

1.99.2.09

3.30-3.66

Males

1.56-1.73

1.91-2.41

3.48-3.96

1.32-1.36

1.61-2.03

3.17-3.55


Disclosure:

E. Kilic,
None;

G. Kilic,
None;

S. Ozgocmen,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-there-any-gender-specific-difference-in-the-cut-off-values-of-ankylosing-spondylitis-disease-activity-score-asdas-in-patients-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology